SE0200943D0 - Mutant protein - Google Patents
Mutant proteinInfo
- Publication number
- SE0200943D0 SE0200943D0 SE0200943A SE0200943A SE0200943D0 SE 0200943 D0 SE0200943 D0 SE 0200943D0 SE 0200943 A SE0200943 A SE 0200943A SE 0200943 A SE0200943 A SE 0200943A SE 0200943 D0 SE0200943 D0 SE 0200943D0
- Authority
- SE
- Sweden
- Prior art keywords
- protein
- immunoglobulin
- binding
- mutated
- glutamine
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/44—Materials comprising a mixture of organic materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/52—Sorbents specially adapted for preparative chromatography
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0200943A SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Mutant protein |
ES03713152T ES2325362T5 (es) | 2002-03-25 | 2003-03-20 | Una proteína de unión a inmunoglobulina mutada |
DK08004374.8T DK1972689T3 (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
US10/508,625 US7834158B2 (en) | 2002-03-25 | 2003-03-20 | Mutated immunoglobulin-binding protein |
KR1020047015303A KR101067181B1 (ko) | 2002-03-25 | 2003-03-20 | 돌연변이된 면역글로불린-결합 단백질 |
ES17166519T ES2783876T3 (es) | 2002-03-25 | 2003-03-20 | Proteína mutante |
EP08004374.8A EP1972689B1 (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
CN038067935A CN1642976B (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
EP17166519.3A EP3249047B1 (en) | 2002-03-25 | 2003-03-20 | Mutant protein |
ES08004374.8T ES2634145T3 (es) | 2002-03-25 | 2003-03-20 | Proteína de unión a inmunoglobulinas mutada |
CA2479896A CA2479896C (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
AT03713152T ATE431360T1 (de) | 2002-03-25 | 2003-03-20 | Mutiertes immunoglobulinbindendes protein |
CN2011104078321A CN102516371A (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
DK17166519.3T DK3249047T3 (en) | 2002-03-25 | 2003-03-20 | Mutantprotein |
DE60327606T DE60327606D1 (de) | 2002-03-25 | 2003-03-20 | Mutiertes immunoglobulinbindendes protein |
AU2003217119A AU2003217119B2 (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
KR1020127028734A KR101307651B1 (ko) | 2002-03-25 | 2003-03-20 | 돌연변이된 면역글로불린-결합 단백질 |
CN201110407855.2A CN102532284B (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
PCT/SE2003/000475 WO2003080655A1 (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
KR1020127028735A KR101307714B1 (ko) | 2002-03-25 | 2003-03-20 | 돌연변이된 면역글로불린-결합 단백질 |
CN2011104134586A CN102558318A (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
CN2011104078514A CN102516372A (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
CN2011104134571A CN102558317A (zh) | 2002-03-25 | 2003-03-20 | 一种突变的免疫球蛋白-结合蛋白 |
KR1020107026798A KR101307700B1 (ko) | 2002-03-25 | 2003-03-20 | 돌연변이된 면역글로불린-결합 단백질 |
EP03713152A EP1485407B2 (en) | 2002-03-25 | 2003-03-20 | A mutated immunoglobulin-binding protein |
JP2003578408A JP4391830B2 (ja) | 2002-03-25 | 2003-03-20 | 変異免疫グロブリン結合タンパク質 |
US11/363,078 US7709209B2 (en) | 2002-03-25 | 2006-02-27 | Protein ligands |
US11/374,532 US20060194950A1 (en) | 2002-03-25 | 2006-03-13 | Mutant protein |
US12/568,854 US8354510B2 (en) | 2002-03-25 | 2009-09-29 | Mutant protein |
US12/900,958 US8198404B2 (en) | 2002-03-25 | 2010-10-08 | Mutated immunoglobulin-binding protein |
US13/488,662 US9156892B2 (en) | 2002-03-25 | 2012-06-05 | Mutated immunoglobulin-binding protein |
US13/740,793 US9296791B2 (en) | 2002-03-25 | 2013-01-14 | Mutant protein |
US14/845,817 US9534023B2 (en) | 2002-03-25 | 2015-09-04 | Mutated immunoglobulin-binding protein |
US15/367,640 US10918971B2 (en) | 2002-03-25 | 2016-12-02 | Mutated immunoglobulin-binding protein |
US17/153,015 US20210162319A1 (en) | 2002-03-25 | 2021-01-20 | Mutated Immunoglobulin-Binding Polypeptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0200943A SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Mutant protein |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0200943D0 true SE0200943D0 (sv) | 2002-03-25 |
Family
ID=20287415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0200943A SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Mutant protein |
Country Status (13)
Country | Link |
---|---|
US (9) | US7834158B2 (sv) |
EP (3) | EP1972689B1 (sv) |
JP (1) | JP4391830B2 (sv) |
KR (4) | KR101307714B1 (sv) |
CN (6) | CN102516372A (sv) |
AT (1) | ATE431360T1 (sv) |
AU (1) | AU2003217119B2 (sv) |
CA (1) | CA2479896C (sv) |
DE (1) | DE60327606D1 (sv) |
DK (2) | DK1972689T3 (sv) |
ES (3) | ES2634145T3 (sv) |
SE (1) | SE0200943D0 (sv) |
WO (1) | WO2003080655A1 (sv) |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Amersham Biosciences Ab | Mutant protein |
SE0301936D0 (sv) * | 2003-06-30 | 2003-06-30 | Affibody Ab | New polypeptide |
SE0400274D0 (sv) * | 2004-02-09 | 2004-02-09 | Affibody Ab | New polypeptide |
EP2251425B1 (en) * | 2004-07-06 | 2016-04-20 | Kaneka Corporation | Process for producing protein A-like protein with use of Brevibacillus genus bacterium |
EP1830947A4 (en) * | 2004-12-14 | 2012-04-18 | Ge Healthcare Bio Sciences Ab | CLEANING OF IMMUNOGLOBULINS |
US8728828B2 (en) | 2004-12-22 | 2014-05-20 | Ge Healthcare Bio-Sciences Ab | Purification of immunoglobulins |
ATE490268T1 (de) * | 2005-03-01 | 2010-12-15 | Affibody Ab | Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird |
EP1992692B1 (en) * | 2006-02-21 | 2013-01-09 | Protenova Co., Ltd. | Immunoglobulin affinity ligand |
CA2664530C (en) | 2006-09-29 | 2015-11-17 | Ge Healthcare Bio-Sciences Ab | Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
WO2008127457A2 (en) | 2006-12-06 | 2008-10-23 | Repligen Corporation | Nucleic acids encoding recombinant protein a |
JP5522723B2 (ja) * | 2007-05-21 | 2014-06-18 | ノマディックバイオサイエンス株式会社 | 新規ポリペプチド,アフィニティークロマトグラフィー用材,及びイムノグロブリンの分離及び/又は精製方法 |
SG149759A1 (en) | 2007-07-10 | 2009-02-27 | Millipore Corp | Media for affinity chromatography |
GB2452301A (en) | 2007-08-30 | 2009-03-04 | Ge Healthcare Bio Sciences Ab | Sterilization Method |
KR101104417B1 (ko) * | 2008-05-09 | 2012-01-16 | 한국생명공학연구원 | 단백질 g 변형체를 이용한 항체의 특이적 공유결합 커플링방법 |
WO2009138484A2 (en) * | 2008-05-15 | 2009-11-19 | Novo Nordisk A/S | Antibody purification process |
US9238810B2 (en) | 2008-06-05 | 2016-01-19 | Affibody Ab | Polypeptide |
US8592555B2 (en) | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
EP2339339A4 (en) * | 2008-09-25 | 2016-10-12 | Jsr Corp | CHARGE FOR AFFINITY CHROMATOGRAPHY |
JP5229888B2 (ja) * | 2008-09-30 | 2013-07-03 | 独立行政法人産業技術総合研究所 | 弱酸性域での易解離性を向上したプロテインa変異型タンパク質及び抗体捕捉剤 |
JP6113404B2 (ja) * | 2008-10-29 | 2017-04-12 | アブリンクス エン.ヴェー. | 単一ドメイン抗原結合分子の精製方法 |
SG162687A1 (en) * | 2008-12-24 | 2010-07-29 | Millipore Corp | Caustic stable chromatography ligands |
CN102272145B (zh) * | 2009-01-12 | 2014-07-30 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
US9403883B2 (en) | 2009-03-24 | 2016-08-02 | Kaneka Corporation | Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
WO2011118699A1 (ja) | 2010-03-24 | 2011-09-29 | 株式会社カネカ | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド |
WO2011125673A1 (ja) | 2010-03-31 | 2011-10-13 | Jsr株式会社 | アフィニティークロマトグラフィー用充填剤 |
US20130052209A1 (en) | 2010-04-23 | 2013-02-28 | Purdue Research Foundation | Protein drug formulations and packages |
WO2012001142A1 (en) | 2010-07-02 | 2012-01-05 | Novo Nordisk A/S | Improved antibody binding affinity ligands |
CA2815267C (en) * | 2010-10-27 | 2019-06-25 | Spiber Technologies Ab | Spider silk fusion protein structures for binding to an organic target |
CN103228328A (zh) * | 2010-11-29 | 2013-07-31 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
JP5974343B2 (ja) * | 2010-12-20 | 2016-08-23 | ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ | アフィニティークロマトグラフィーマトリックス |
CN103269761B (zh) | 2010-12-20 | 2016-05-18 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
US9051375B2 (en) | 2010-12-21 | 2015-06-09 | The University Of Western Ontario | Alkali-resistant variants of protein A and their use in affinity chromatography |
US9040661B2 (en) | 2010-12-21 | 2015-05-26 | Jsr Corporation | Support for affinity chromatography and method for isolating immunoglobulin |
EP2657254A4 (en) * | 2010-12-24 | 2014-01-08 | Asahi Kasei Medical Co Ltd | PROCESS FOR IMMOBILIZING THE TEMPERATURE-REACTIVE PROTEIN A |
CN103299231B (zh) | 2011-01-20 | 2017-07-21 | 通用电气医疗集团生物科学公司 | 光扫描系统 |
WO2012124145A1 (ja) | 2011-03-15 | 2012-09-20 | オムロン株式会社 | 演算ユニット、支援装置、支援プログラム、支援プログラムを格納した記憶媒体、および、支援装置における動作方法 |
JP6038774B2 (ja) | 2011-03-24 | 2016-12-07 | 株式会社カネカ | タンパク性物質結合性低分子化合物 |
WO2012133342A1 (ja) | 2011-03-25 | 2012-10-04 | 株式会社カネカ | 免疫グロブリン結合性新規ポリペプチド |
JP5802830B2 (ja) * | 2011-06-05 | 2015-11-04 | アップル インコーポレイテッド | 複数のアプリケーションから受信した通知を表示するためのシステムおよび方法 |
SG10201604559TA (en) | 2011-06-08 | 2016-07-28 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
US9657055B2 (en) | 2011-11-30 | 2017-05-23 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
WO2013147691A1 (en) | 2012-03-28 | 2013-10-03 | Ge Healthcare Bio-Sciences Ab | Affinity chromatography matrix |
US9856308B2 (en) * | 2012-05-02 | 2018-01-02 | Spiber Technologies Ab | Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands |
JP6335785B2 (ja) | 2012-09-03 | 2018-05-30 | 株式会社カネカ | ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子 |
CN104718453B (zh) | 2012-10-03 | 2017-03-08 | Gyros专利公司 | 酸性条件下分析物测定用方法和试剂盒 |
US20150328563A1 (en) | 2012-12-14 | 2015-11-19 | Ge Healthcare Bio-Sciences Ab | Method for Cleaning of Packed Bed Chromatography Columns |
CN104059133B (zh) * | 2013-03-18 | 2019-03-15 | 南京金斯瑞生物科技有限公司 | 一类突变的具有高耐碱特性的蛋白a及其应用 |
CN103214563B (zh) * | 2013-03-26 | 2015-09-30 | 江南大学 | 一种性能改进的重组金黄色葡萄球菌蛋白a亲和配基及其构建方法 |
US9896486B2 (en) | 2013-07-10 | 2018-02-20 | Ge Healthcare Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
US10208094B2 (en) | 2013-09-04 | 2019-02-19 | Protenova Co., Ltd. | Multimeric immunoglobulin-binding domain |
EP3042954A4 (en) * | 2013-09-06 | 2017-03-22 | Kaneka Corporation | Dissociation capacity-boosted ligand for affinity dissociation matrix |
CN105555795A (zh) | 2013-09-17 | 2016-05-04 | 株式会社钟化 | 新抗体纯化方法和由该方法得到的抗体、以及使用了阳离子交换基团的新抗体纯化法和由该方法得到的抗体 |
CN103540588B (zh) * | 2013-10-08 | 2016-06-08 | 杨波 | 一种基因工程改造的免疫球蛋白-亲和蛋白 |
WO2015056680A1 (ja) | 2013-10-15 | 2015-04-23 | 株式会社カネカ | 多孔質セルロースビーズの製造方法 |
EP3059320A4 (en) | 2013-10-15 | 2017-06-21 | Kaneka Corporation | Production method for porous cellulose beads, and absorbent employing same |
WO2015056681A1 (ja) | 2013-10-15 | 2015-04-23 | 株式会社カネカ | 多孔質セルロースビーズの製造方法およびそれを用いた吸着体 |
CN104945488B (zh) * | 2014-03-27 | 2020-02-18 | 迈格生物医药(上海)有限公司 | 一种具有免疫球蛋白结合能力的多肽 |
CN105481954B (zh) * | 2014-09-16 | 2021-03-26 | 亿一生物制药(北京)有限公司 | 一种重组蛋白a及其应用 |
JP6369807B2 (ja) * | 2014-10-21 | 2018-08-08 | 株式会社プロテイン・エクスプレス | プロテインl変異体 |
US11566082B2 (en) * | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
CN116731129A (zh) | 2014-12-17 | 2023-09-12 | 思拓凡生物工艺研发有限公司 | 修饰的κ轻链-结合多肽 |
WO2016121703A1 (ja) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | 変異型免疫グロブリンκ鎖可変領域結合性ペプチド |
WO2016121701A1 (ja) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス |
EP3255058B1 (en) | 2015-02-05 | 2021-03-24 | Mitsubishi Chemical Corporation | Protein having affinity to immunoglobulin, and affinity separation medium and column for liquid chromatography using same |
US10723769B2 (en) * | 2015-03-26 | 2020-07-28 | Jsr Corporation | Immunoglobulin-binding protein and affinity carrier using same |
CN106188251B (zh) * | 2015-05-06 | 2020-07-31 | 上海迈泰君奥生物技术有限公司 | 一种免疫球蛋白结合蛋白突变体及其用途 |
JPWO2017014261A1 (ja) * | 2015-07-22 | 2018-04-26 | 株式会社カネカ | 抗体様タンパク質の精製方法 |
CN107849095A (zh) * | 2015-07-22 | 2018-03-27 | 株式会社钟化 | 酸性pH范围内的抗体结合能力降低的抗体结合性蛋白质 |
GB201515339D0 (en) | 2015-08-28 | 2015-10-14 | Ge Healthcare Bio Sciences Ab | A seperation matrix and a method of seperating antibodies |
KR101993845B1 (ko) * | 2016-02-18 | 2019-06-28 | (주)에이피테크놀로지 | 알칼리 저항성이 증대된 항체 친화성 리간드 |
WO2017191748A1 (ja) * | 2016-05-02 | 2017-11-09 | 株式会社カネカ | 改変型免疫グロブリンκ鎖可変領域結合性ペプチド |
WO2017195638A1 (ja) | 2016-05-09 | 2017-11-16 | 株式会社カネカ | 抗体またはκ鎖可変領域含有抗体断片の精製方法 |
US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
CN109311949B (zh) * | 2016-05-11 | 2022-09-16 | 思拓凡生物工艺研发有限公司 | 储存分离基质的方法 |
US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
ES2909833T3 (es) | 2016-05-11 | 2022-05-10 | Cytiva Bioprocess R & D Ab | Método de limpieza y/o desinfección de una matriz de separación |
US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
ES2874974T3 (es) | 2016-05-11 | 2021-11-05 | Cytiva Bioprocess R & D Ab | Matriz de separación |
KR101857953B1 (ko) | 2016-07-06 | 2018-05-16 | 아미코젠주식회사 | 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질 |
CN106117324A (zh) * | 2016-07-29 | 2016-11-16 | 湖北爱晟生物科技有限公司 | 重组蛋白a及其编码基因和应用 |
KR102578256B1 (ko) * | 2016-08-11 | 2023-09-15 | 리플리겐 코포레이션 | 친화성 크로마토그래피를 위한 알칼리 안정 fc-결합 단백질 |
WO2018048941A2 (en) * | 2016-09-08 | 2018-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Use of high affinity monoclonal antibody product binders to increase the duration of action of therapeutic monoclonal antibody products in a biologic tissue |
CN106543274B (zh) * | 2016-10-18 | 2020-10-27 | 天津大学 | 一种对抗体具有特异性结合作用的a蛋白结构域z的衍生物及其应用 |
JP2020504172A (ja) | 2016-12-12 | 2020-02-06 | フラー エス.アー.エール.エル. | 免疫グロブリン結合ポリペプチドおよびオリゴペプチドの免疫グロブリン結合容量を増加するための組成物および方法 |
GB201703116D0 (en) | 2017-02-27 | 2017-04-12 | Ge Healthcare Bioprocess R&D Ab | A seperation matrix and a method of seperating antibodies |
WO2019030156A1 (en) | 2017-08-07 | 2019-02-14 | Repligen Corporation | FC BINDING PROTEINS WITH CYSTEINE IN THE C-TERMINAL HELICAL REGION |
CN109721645A (zh) * | 2017-12-29 | 2019-05-07 | 兆生生物科技南京有限公司 | 一种基因突变的蛋白a及其应用 |
US11155575B2 (en) | 2018-03-21 | 2021-10-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbent, devices and methods |
JP7335881B2 (ja) * | 2018-08-24 | 2023-08-30 | Jsr株式会社 | イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体 |
WO2020075670A1 (ja) * | 2018-10-10 | 2020-04-16 | 国立大学法人鹿児島大学 | IgG結合性ペプチドを含む固相担体及びIgGの分離方法 |
EP3917942A1 (en) * | 2019-02-01 | 2021-12-08 | Navigo Proteins Gmbh | Immunoglobulin binding proteins for affinity purification |
WO2020196938A1 (ko) * | 2019-03-25 | 2020-10-01 | 아미코젠주식회사 | 불순물 제거능이 우수한 항체 정제용 레진 |
GB201904125D0 (en) | 2019-03-26 | 2019-05-08 | Ge Healthcare Bio Sciences Ab | Method for sanitization of a chromatography column |
JP2022530852A (ja) * | 2019-04-17 | 2022-07-04 | ブリストル-マイヤーズ スクイブ カンパニー | クロマトグラフィー樹脂の再生方法 |
WO2020221781A1 (en) | 2019-04-29 | 2020-11-05 | Cytiva Bioprocess R&D Ab | Method for separation of antibodies or antibody fragments being devoid of an fc region capable of binding to protein a |
CN112210013A (zh) | 2019-07-03 | 2021-01-12 | 拜奥普罗塞亚科技有限责任公司 | 碱耐受性亲和色谱配体 |
EP4049684A4 (en) | 2019-10-18 | 2023-10-25 | Nihon Medi-Physics Co., Ltd | RI MARKED HUMANIZED ANTIBODIES |
CN111057153B (zh) * | 2019-12-06 | 2021-09-07 | 广州康盛生物科技股份有限公司 | 一种免疫球蛋白结合蛋白及其制备方法和应用 |
CN112461943A (zh) * | 2020-10-12 | 2021-03-09 | 河南省奶牛生产性能测定有限公司 | 一种牛乳中免疫球蛋白igG高效液相色谱检测方法 |
WO2022081779A1 (en) | 2020-10-13 | 2022-04-21 | Avitide LLC | Affinity ligand libraries of three-helix bundle proteins and uses thereof |
GB202018588D0 (en) | 2020-11-26 | 2021-01-13 | Cytiva Bioprocess R & D Ab | Separation matrix |
WO2022136440A1 (en) | 2020-12-21 | 2022-06-30 | Syngenta Crop Protection Ag | Pesticidal hexatoxin polypeptides and methods of use thereof |
JP2024508587A (ja) | 2021-02-19 | 2024-02-28 | アヴィタイド エルエルシー | Aav2親和剤 |
KR20230174238A (ko) | 2021-04-21 | 2023-12-27 | 니혼 메디피직스 가부시키가이샤 | 방사성 항종양제 |
CA3217638A1 (en) | 2021-04-21 | 2022-10-27 | Nihon Medi-Physics Co., Ltd. | Humanised antibodies labelled with radionuclides that emit .beta.-rays |
GB2609185A (en) | 2021-05-24 | 2023-02-01 | Astrea Uk Services Ltd | Scaffold for isolation of a biomolecule |
GB202109246D0 (en) | 2021-06-28 | 2021-08-11 | Cytiva Bioprocess R & D Ab | A method of separating bispecific antibodies |
GB202113626D0 (en) | 2021-09-24 | 2021-11-10 | Cytiva Bioprocess R & D Ab | FC binding polypeptides |
CN114315996B (zh) * | 2021-12-31 | 2023-01-17 | 博格隆(浙江)生物技术有限公司 | 一种重组ProteinA蛋白及亲和层析介质的制备方法 |
CN114409748A (zh) * | 2022-01-28 | 2022-04-29 | 博格隆(浙江)生物技术有限公司 | 蛋白a的b结构域和z结构域突变体及其应用 |
GB202203478D0 (en) | 2022-03-14 | 2022-04-27 | Cytiva Bioprocess R & D Ab | Vh3 binding polypeptides |
CN114605508B (zh) * | 2022-05-11 | 2022-07-29 | 北京达成生物科技有限公司 | 能够结合于抗体分子Fc区域的抗体结合蛋白及其应用 |
CN117700501A (zh) * | 2022-09-13 | 2024-03-15 | 普米斯生物技术(珠海)有限公司 | 免疫球蛋白结合蛋白及其应用 |
CN117024529B (zh) * | 2023-07-17 | 2024-01-26 | 北京达成生物科技有限公司 | 抗体结合蛋白及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8505922D0 (sv) | 1985-12-13 | 1985-12-13 | Kabigen Ab | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
WO1993002107A1 (en) | 1991-07-25 | 1993-02-04 | Oriental Yeast Co., Ltd. | Immunoglobulin-combining artificial protein |
SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
US5834597A (en) * | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
GB9823071D0 (en) | 1998-10-21 | 1998-12-16 | Affibody Technology Ab | A method |
US7709209B2 (en) * | 2002-03-25 | 2010-05-04 | Ge Healthcare Bio-Sciences Ab | Protein ligands |
SE0200943D0 (sv) * | 2002-03-25 | 2002-03-25 | Amersham Biosciences Ab | Mutant protein |
JP4871126B2 (ja) * | 2003-07-04 | 2012-02-08 | アフィボディ・アーベー | Her2に対する結合親和性を有するポリペプチド |
US8728828B2 (en) * | 2004-12-22 | 2014-05-20 | Ge Healthcare Bio-Sciences Ab | Purification of immunoglobulins |
ATE490268T1 (de) * | 2005-03-01 | 2010-12-15 | Affibody Ab | Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird |
CN102272145B (zh) * | 2009-01-12 | 2014-07-30 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
US9051375B2 (en) * | 2010-12-21 | 2015-06-09 | The University Of Western Ontario | Alkali-resistant variants of protein A and their use in affinity chromatography |
US9896486B2 (en) * | 2013-07-10 | 2018-02-20 | Ge Healthcare Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
US11566082B2 (en) * | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
US10654887B2 (en) * | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
US10730908B2 (en) * | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10703774B2 (en) * | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
-
2002
- 2002-03-25 SE SE0200943A patent/SE0200943D0/sv unknown
-
2003
- 2003-03-20 EP EP08004374.8A patent/EP1972689B1/en not_active Expired - Lifetime
- 2003-03-20 DK DK08004374.8T patent/DK1972689T3/en active
- 2003-03-20 EP EP03713152A patent/EP1485407B2/en not_active Expired - Lifetime
- 2003-03-20 US US10/508,625 patent/US7834158B2/en active Active
- 2003-03-20 DK DK17166519.3T patent/DK3249047T3/da active
- 2003-03-20 ES ES08004374.8T patent/ES2634145T3/es not_active Expired - Lifetime
- 2003-03-20 AU AU2003217119A patent/AU2003217119B2/en not_active Expired
- 2003-03-20 CN CN2011104078514A patent/CN102516372A/zh active Pending
- 2003-03-20 CN CN2011104078321A patent/CN102516371A/zh active Pending
- 2003-03-20 ES ES03713152T patent/ES2325362T5/es not_active Expired - Lifetime
- 2003-03-20 WO PCT/SE2003/000475 patent/WO2003080655A1/en active Application Filing
- 2003-03-20 CN CN038067935A patent/CN1642976B/zh not_active Expired - Lifetime
- 2003-03-20 KR KR1020127028735A patent/KR101307714B1/ko active IP Right Grant
- 2003-03-20 CN CN2011104134571A patent/CN102558317A/zh active Pending
- 2003-03-20 JP JP2003578408A patent/JP4391830B2/ja not_active Expired - Lifetime
- 2003-03-20 KR KR1020047015303A patent/KR101067181B1/ko active IP Right Grant
- 2003-03-20 KR KR1020127028734A patent/KR101307651B1/ko active IP Right Grant
- 2003-03-20 DE DE60327606T patent/DE60327606D1/de not_active Expired - Lifetime
- 2003-03-20 CA CA2479896A patent/CA2479896C/en not_active Expired - Lifetime
- 2003-03-20 AT AT03713152T patent/ATE431360T1/de not_active IP Right Cessation
- 2003-03-20 KR KR1020107026798A patent/KR101307700B1/ko active IP Right Grant
- 2003-03-20 CN CN2011104134586A patent/CN102558318A/zh active Pending
- 2003-03-20 ES ES17166519T patent/ES2783876T3/es not_active Expired - Lifetime
- 2003-03-20 EP EP17166519.3A patent/EP3249047B1/en not_active Expired - Lifetime
- 2003-03-20 CN CN201110407855.2A patent/CN102532284B/zh not_active Expired - Lifetime
-
2006
- 2006-03-13 US US11/374,532 patent/US20060194950A1/en not_active Abandoned
-
2009
- 2009-09-29 US US12/568,854 patent/US8354510B2/en not_active Expired - Lifetime
-
2010
- 2010-10-08 US US12/900,958 patent/US8198404B2/en not_active Expired - Fee Related
-
2012
- 2012-06-05 US US13/488,662 patent/US9156892B2/en not_active Expired - Lifetime
-
2013
- 2013-01-14 US US13/740,793 patent/US9296791B2/en not_active Expired - Fee Related
-
2015
- 2015-09-04 US US14/845,817 patent/US9534023B2/en not_active Expired - Lifetime
-
2016
- 2016-12-02 US US15/367,640 patent/US10918971B2/en not_active Expired - Lifetime
-
2021
- 2021-01-20 US US17/153,015 patent/US20210162319A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0200943D0 (sv) | Mutant protein | |
WO2004035752A3 (en) | ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS | |
BRPI0409269A (pt) | anticorpo modificado da classe igg e método de produção do mesmo | |
WO2008048545A3 (en) | Molecules with reduced half-lives, compositions and uses thereof | |
EP2157099B1 (en) | Novel immunoglobulin-binding proteins with improved specificity | |
PL1601770T3 (pl) | Antygeny Streptococcus pyogenes | |
AU2002367839A8 (en) | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | |
WO2005037867B1 (en) | ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG | |
WO2004074310A8 (en) | Mycobacterial diagnostics | |
NO20025656D0 (no) | Opplöselige CTLA4 mutantmolekyler og anvendelser derav | |
JP2008506960A5 (sv) | ||
McCue et al. | Validation of the manufacturing process used to produce long‐acting recombinant factor IX Fc fusion protein | |
PT1944371E (pt) | Antigénios e composições da neisseria meningitidis | |
WO2004081186A3 (en) | Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof | |
RU2010125489A (ru) | Способ характеризации рекомбинантного поликлонального белка | |
JPWO2006001300A1 (ja) | 高耐久性液体クロマトグラフィー用充填剤 | |
Krepper et al. | Temperature dependence of antibody adsorption in protein A affinity chromatography | |
Yoshida et al. | Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. | |
EP1960427A4 (en) | MULTIMED FC RECEPTOR POLYPEPTIDES | |
ATE480573T1 (de) | Pfropfcopolymere, deren herstellung und verwendung bei der kapillarelektrophorese | |
WO2006073971A3 (en) | Binding protein with a scaffold for varying specificity | |
WO2004106367A3 (en) | Enterococcus antigens | |
WO2002062988A3 (en) | Recombination method | |
WO2002095067A3 (en) | INTERFERON α-14 POLYMORPHISM | |
ATE350387T1 (de) | Verfahren zur reinigung von molekülen unter verwendung von unverzweigten alkyldiolen mit einständigen hydroxylgruppen |